Related Experiment Video
Updated: May 28, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Heat shock protein as molecular targets for breast cancer therapeutics
1Division of Breast and Endocrine Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
Abstract:
Recent advances in the understanding of the molecular mechanisms involved in the breast cancer development and progression have led to the identification of numerous novel molecular targets. Among these, heat shock proteins (HSPs) are being emerging molecular target due to its diverse function in cancer cells. HSPs are highly conserved molecular chaperone that are synthesized by cell in response to various stress conditions. Mammalian HSPs have been classified into several families according to their molecular weight: HSP100, HSP90, HSP72, and small molecular HSPs (including HSP27). They are essential proteins that play a key role in cell survival through the cytoprotective mechanisms. In addition, HSPs are often overexpressed in a rage of cancers including breast cancer, and its overexpression seems to be associated with poor clinical outcomes. Also, HSP90 play a role in facilitating transformation by stabilizing the mutated and overexpressed oncoproteins found in breast cancer cell. Pharmacological targeting of HSP is therefore indicated and in the case of HSP90, numerous inhibitory drugs are undergoing clinical trial for treatment of breast cancer and other cancers. In this review, we describe the roles of HSPs in cancer cell and introduce the HSPs inhibitor as molecular target in cancer therapy and its recent clinical trials in breast cancer.
Insights
Heat shock proteins (HSPs) are crucial for cancer cell survival and progression. Targeting HSPs, particularly HSP90, shows promise as a novel therapeutic strategy for breast cancer, with several inhibitors in clinical trials.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Heat shock proteins (HSPs) are molecular chaperones involved in cellular stress response.
- HSPs are frequently overexpressed in various cancers, including breast cancer, correlating with poor prognosis.
- HSP90 stabilizes oncoproteins, promoting cancer cell transformation and survival.
Purpose of the Study:
- To review the multifaceted roles of HSPs in cancer cell biology.
- To highlight HSP inhibitors as a promising molecular target for cancer therapy.
- To summarize recent clinical trials investigating HSP inhibitors in breast cancer treatment.
Main Methods:
- Literature review of HSP functions in cancer.
- Analysis of HSP overexpression in breast cancer and its clinical implications.
- Overview of HSP inhibitor development and clinical trial data.
Main Results:
- HSPs play critical roles in maintaining cancer cell viability and promoting tumor progression.
- HSP90 is a key facilitator of oncogenic protein stability in breast cancer.
- Multiple HSP90 inhibitors are in clinical trials for breast cancer and other malignancies.
Conclusions:
- HSPs represent significant molecular targets for novel cancer therapies.
- Targeting HSPs, especially HSP90, offers a promising therapeutic avenue for breast cancer.
- Ongoing clinical trials are evaluating the efficacy and safety of HSP inhibitors in breast cancer patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle
Bacterial Protein Maturation
Other Stress Responses in Bacteria
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Molecular Chaperones and Protein Folding
The...

